Catalyst Wire Dossier Catalyst Wire Dossier

Invanz

ertapenem · Merck & Co.
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Invanz, covering 2007-07-13 to 2025-11-21. Get the full timeline:

Most recent: EMA Authorised: Invanz (ertapenem sodium) — Merck Sharp & Dohme B.V.

See pricing